Zogenix, Inc.

Zogenix, Inc. is a pharmaceutical company engaged in developing and commercializing central nervous system (CNS) therapies that address specific clinical needs for people living with orphan and other CNS disorders in requirement of treatment alternatives. The Company's areas of focus are epilepsy and schizophrenia. Its lead product candidate, ZX008, is a low-dose fenfluramine. The Company is also engaged in the development of Relday, which is a long-acting injectable formulation of risperidone indicated for the treatment of symptoms of schizophrenia and bipolar disorder in adults and teenagers 13 years of age and older. The Company is also engaged in manufacturing Sumavel DosePro (sumatriptan injection), a needle-free delivery system, which it sells to Endo Ventures Bermuda Limited and Endo Ventures Limited. Its DosePro technology is a drug delivery system designed for self-administration of a pre-filled, single dose of liquid drug, subcutaneously, without a needle.  
 

News

SITO Mobile, Ltd. (NASDAQ:SITO) Appoints CEO, Solidifies Top Management

🕔7/22/2017 1:45:00 AM 3148

(NetworkNewsWire) After a recent shakeup, New Jersey-based SITO Mobile, Inc. (NASDAQ:SITO) has appointed a new CEO, COO, chairman of the board and board members to its management team, and it is back on track doing what the company does best, helping advertisers attract customers using mobile platforms.

Read Full Article

Zogenix, Inc. (ZGNX) Develops Orphan Drug for Dravet Syndrome Epilepsy

🕔12/1/2016 8:30:00 AM 847

Zogenix, Inc (NASDAQ:ZGNX) is a clinical stage pharmaceutical company committed to the development and commercialization of therapies for central nervous system disorders that address specific clinical needs for people living with orphan diseases. The company's lead product candidate, ZX008, is currently being evaluated for the treatment of one such disease - Dravet Syndrome.

Read Full Article
###

1,620 COMPANY PROFILE VIEWS

  • This Page Viewed: (Last 7 Days: 2) (Last 30 Days: 10) (Since Published: 1620) 

Company Data